熱門資訊> 正文

INDVIO Pharmaceuticals提议证券发行

2026-04-02 14:22

Inovio製藥(INO) 0

INOVIO Pharmaceuticals (INO) plans to sell common shares and accompanying Series A warrants and Series B warrants (or pre-funded warrants to purchase its common stock in lieu thereof), in an underwritten public offering.
The company will also give underwriters a 30-day option to buy up to 15% more shares and warrants. The offering is subject to market conditions, and its size and timing are not yet finalized.

More on Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
Inovio Pharmaceuticals, Inc. (INO) Q4 2025 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (INO) Presents at The Citizens Life Sciences Conference 2026 Transcript
Inovio targets October 30 PDUFA date for INO-3107 approval while extending cash runway into Q4 2026
Inovio Pharmaceuticals Q4 2025 Earnings Preview

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。